Invention Grant
- Patent Title: Heteroaryl orexin receptor antagonists
-
Application No.: US15531887Application Date: 2015-12-14
-
Publication No.: US10239838B2Publication Date: 2019-03-26
- Inventor: Scott D. Kuduk , Nigel Liverton , Yunfu Luo
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent J. Eric Thies; John C. Todaro
- Priority: WOPCT/CN2014/094370 20141219
- International Application: PCT/US2015/065444 WO 20151214
- International Announcement: WO2016/100156 WO 20160623
- Main IPC: C07D401/12
- IPC: C07D401/12 ; C07D213/40 ; C07D403/12 ; C07D401/14 ; C07D213/82
Abstract:
The present invention is directed to heteroaryl compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.
Public/Granted literature
- US20170260136A1 HETEROARYL OREXIN RECEPTOR ANTAGONISTS Public/Granted day:2017-09-14
Information query
